Trading Symbol: MCV
TORONTO, Nov. 8, 2012 /CNW/ - McVicar Industries Inc. ("McVicar") is pleased to announce that Dr. Evelyn Su has been appointed to the Board of Directors of McVicar. Dr. Su is a US citizen and obtained her Ph.D. in Chemistry from the University of Connecticut, USA. She worked for the US pharmaceutical giant, Pfizer Inc., in the early 1990s before she co-founded Sino Lion (USA), Ltd., a chemical company specialized in personal care and pharmaceutical products with manufacturing operations in China.
"I am very pleased with the addition of Dr. Su to our board." commented Dr. Gang Chai, CEO of McVicar. "Her expertise in the chemical industry and extensive experience in China will add great value to McVicar."
The appointment is subject to regulatory approval.
McVicar Industries Inc., headquartered in Toronto, Canada, is focused on investments and acquisitions of businesses in China. At present, McVicar has operations in both electronic components and specialty chemicals in four operations in China.
This press release contains forward-looking statements which reflect the Corporation's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize.
The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
SOURCE: McVicar Industries Inc.